Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Navani

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Thorax|January 21, 2019
Impact of organisation and specialist service delivery on lung cancer outcomesJana Bhavani Adizie, Aamir Khakwani, Paul Beckett, et al.
Chest|February 26, 2022
Frailty in Patients With Lung Cancer: A Systematic Review and Meta-AnalysisKlara Komici, Leonardo Bencivenga, Neal Navani, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trialMatthew Hatton, Matthew Nankivell, Ethan Lyn, et al.
The Lancet. Digital Health|January 26, 2024
Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic reviewRebecca Giddings, Anabel Joseph, Thomas Callender, et al.
Plos Medicine|October 3, 2023
Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation studyThomas Callender, Fergus Imrie, Bogdan Cebere, et al.
Thorax|November 23, 2011
Pulmonary mass in a 19-year-old male. Inflammatory myofibroblastic tumourLaura-Jane E Smith, David R Lawrence, Irfan Kayani, et al.
BMJ Open Respiratory Research|October 31, 2025
Sublobar resection or lobectomy for stage Ia non-small cell lung cancer: a systematic review and meta-analysisLauren Kari Dixon, Ella Barber, Adrian Cook, et al.
International Journal of Molecular Sciences|May 10, 2019
Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly PatientsFabio Perrotta, Danilo Rocco, Fabiana Vitiello, et al.
ERJ Open Research|April 6, 2023
What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modellingMatthew Evison, Ross Maconachie, Toby Mercer, et al.
JTO Clinical and Research Reports|November 24, 2025
Risk Factors Associated With Incidence of Lung Cancer in Never-Smokers: A Systematic Review and Meta-AnalysisSindhu Bhaarrati Naidu, Allegra Wisking, Akul Karoshi, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Thorax|January 21, 2019
Impact of organisation and specialist service delivery on lung cancer outcomesJana Bhavani Adizie, Aamir Khakwani, Paul Beckett, et al.
Chest|February 26, 2022
Frailty in Patients With Lung Cancer: A Systematic Review and Meta-AnalysisKlara Komici, Leonardo Bencivenga, Neal Navani, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trialMatthew Hatton, Matthew Nankivell, Ethan Lyn, et al.
The Lancet. Digital Health|January 26, 2024
Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic reviewRebecca Giddings, Anabel Joseph, Thomas Callender, et al.
Plos Medicine|October 3, 2023
Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation studyThomas Callender, Fergus Imrie, Bogdan Cebere, et al.
Thorax|November 23, 2011
Pulmonary mass in a 19-year-old male. Inflammatory myofibroblastic tumourLaura-Jane E Smith, David R Lawrence, Irfan Kayani, et al.
BMJ Open Respiratory Research|October 31, 2025
Sublobar resection or lobectomy for stage Ia non-small cell lung cancer: a systematic review and meta-analysisLauren Kari Dixon, Ella Barber, Adrian Cook, et al.
International Journal of Molecular Sciences|May 10, 2019
Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly PatientsFabio Perrotta, Danilo Rocco, Fabiana Vitiello, et al.
ERJ Open Research|April 6, 2023
What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modellingMatthew Evison, Ross Maconachie, Toby Mercer, et al.
JTO Clinical and Research Reports|November 24, 2025
Risk Factors Associated With Incidence of Lung Cancer in Never-Smokers: A Systematic Review and Meta-AnalysisSindhu Bhaarrati Naidu, Allegra Wisking, Akul Karoshi, et al.
Pageof 13